Related Experiment Video
Updated: Aug 16, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Lipid peroxidation products and changes in phospholipid composition induced by indobufen in diabetic platelets
A Dmoszyńska1, A Walter-Croneck, A Ledwozyw
1Department of Haematology, Univ. Med. School in Lublin, Poland.
Abstract:
Indobufen is an antiaggregatory drug which first of all inhibits platelet aggregation by interfering with cyclooxygenase enzymes in platelets. We have investigated the influence of indobufen (200 mg twice daily for 10 days) on platelet lipid peroxidation and phospholipid metabolism in diabetic patients. The production of lipid peroxidation products was significantly lower after drug treatment. Indobufen administration, however, had no influence on the fatty acid composition of platelet phospholipids.
More Related Videos
08:20Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
10:31A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
Published on: September 26, 2025
Related Concept Videos
Inflammation
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
Diabetic Retinopathy